The JAMA Report Channel

Longer Duration of Blood-Thinning Medications May Not Be Necessary for Patients with Newer Generation Coronary Stents

The JAMA Report

After receiving a coronary stent to repair a blocked artery to the heart, patients are given blood-thinning medications. This can help prevent clots from forming in the stent. A new study examined whether patients with a newer generation, drug-releasing stent can reduce the number of months they take blood-thinning medications without increasing complication risks. Catherine Dolf explains in this week’s JAMA Report.

More in The JAMA Report

► 1:54

Wealth-Associated Disparities in Death and Disability in the United States and England

Family Medicine

Although life expectancy has increased worldwide, differences in death rates among socioeconomic groups continue to grow in the United States and Europe. But are there differences in the relationship between...

► 1:41

Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality

The JAMA Report

Menopausal hormone therapy involves a complex balance of risk and benefit for women. A new study based on the Women’s Health Initiative hormone therapy trials examined total risk of death...

► 2:12

Neighborhood Demographics and Cardiac Arrest Treatments and Outcomes

Cardiology

In a cardiac arrest, the heart suddenly stops beating. About 350,000 patients have a cardiac arrest outside the hospital each year in the United States. Only 8% to 10% survive...

► 2:14

Evaluation of Chronic Traumatic Encephalopathy in Football Players

Human Interest

Chronic traumatic encephalopathy, or CTE, is a progressive degenerative brain disease associated with repetitive head trauma. Currently, CTE can only be confirmed post-mortem. In a new study from JAMA, researchers...